Lichen-forming fungi are unique organisms, producing biologically active metabolites with a great variety of effects, including antibiotic, antimycobacterial, antiviral, anti-inflammatory, analgesic, antipyretic, antiproliferative and cytotoxic activities. However, only very limited numbers of lichen substances have been screened for their biological activities and their therapeutic potential in medicine. This is certainly due to the difficulties encountered in identification of the species, collection of bulk quantities, and the isolation of pure substances for structure determination and testing activity. Recently, possibilities for bypassing some of these former difficulties have arisen by the introduction of new techniques. This includes axenic cultivation for production of the genuine compounds or new ones, extraction of focused compounds, or synthesis of natural products or their derivatives for testing. Utilizing these new opportunities, the discovery of novel active metabolites, which could serve as lead compounds, is significantly facilitated. At the same time, the evolution of secondary metabolite patterns is studied using phylogenetic approaches. Yet, the genetic background of the complex chemical patterns is poorly understood. The scattered occurrence of some compounds suggests that their production evolved either in parallel or that ancient biosynthetic pathways are abandoned in many lineages. At least, studies on polyketide synthase genes from different lichen groups suggest a high level of gene paralogy. In this context, clades of orthologous polyketide synthase genes, which are often shared with distantly related non-lichenized fungi, can roughly be identified by their sequence similarity and their similar patterns of substitution rates. The functional assignment of paralogs is nevertheless difficult and reasonable only in a few cases. A global approach of the lichen metabolomic features appears to be essential in developing new and viable biotechnological processes which could afford suitable amounts of unique lichen compounds.
Introduction
Lichens are characterized as a stable and self-supporting association between fungi-the mycobionts-and photoautotrophic, algal partners-the photobionts. Since the mycobiont is unique in the symbiotic association and usually dominates the association, lichens are traditionally classified as a life-form of fungi. As an apparently successful form of fungal symbioses, the lichen-forming habit is maintained by one-fifth of all fungi, which includes more than ca 40% of ascomycetes, but only a few basidiomycetes. About 18,500 different lichen species have been described all over the world. They may grow under rather diverse and sometimes extreme ecological conditions. Lichens can be found in very cold and dry environments, either at polar latitudes or at extreme altitudes (up to 7400 m). Perhaps the other extreme are lichens which have adapted to tropical rainforest habitats, and may even grow on the surface of living leaves. Despite this extreme range of ecological adaptations, most lichens are sensitive to changes of their preferred ecological conditions and can hardly grow in nonnative habitats.
Wherever lichens grow abundantly in nature, they often add a colourful aspect to their habitat. The distinct colours of many lichens are due to the massive accumulation of diverse secondary compounds, the 'lichen substances'. These represent comparatively small, but also chemically complex molecules. Beside the externally visible crystallized and non-crystallized pigments that are deposited in the upper surface layers of the lichen's vegetative body, also colourless substances are common, which are predominantly found in internal parts of the thalli.
The first reports on chemical differences in lichens stem back to the middle of the 19th century, yet, the initial contributions to lichen chemistry were clearly provided by the studies of Wilhelm Zopf, a German chemist (Zopf, 1895; and subsequent publications) . A further milestone in lichen chemistry is attributable to the works of Japanese researchers Yasuhiko Asahina and Shoii Shibata, who-together with their co-authors-elucidated the chemical structures of numerous compounds, described their synthesis and introduced the identification of lichen substances by micro-recrystallization (e.g. Asahina, 1936; Shibata, 1958 Shibata, , 2000 and citations therein) . In the second half of the 20th century, thinlayer chromatography became a routine technology, and was broadly applied to study the presence of compounds in diverse lichens. As a consequence, secondary compounds were extensibly used as characters at different hierarchic levels in the classification, in an approach called chemotaxonomy. At its rise in lichenology, a compilation of data for about 430 substances, including their occurrences in lichen species, was published as three influential books (Culberson, 1969 (Culberson, , 1970 Culberson et al., 1977) . The number of known substances from lichens increased to more than 800 in the last major compilation (Huneck and Yoshimura, 1996; Huneck, 2001) , while many more still need to be characterized (J. A. Elix, personal communication).
Diversity of secondary compounds in lichens
Structures of some common and unusual compounds in lichens are presented in Fig. 1 .
According to their chemical structures, most lichen substances are phenolic compounds (orcinol and b-orcinol derivatives), dibenzofuranes and usnic acids (e.g. usnic acid), depsides (e.g. barbatic acid), depsidones (e.g. salazinic acid), depsones (e.g. picrolichenic acid), lactones (e.g. protolichesterinic acid, nephrosterinic acid), quinones (e.g. parietin), and pulvinic acid derivatives (e.g. vulpinic acid). Lichens apparently evolved diverse biosynthetic pathways to produce this diversity of compounds: mainly polymalonate, shikimic acid and mevalonic acid pathways.
Apart from compounds derived from these common pathways, which are found throughout all major lichen groups, there are also some unusual compound classes among these organisms; for example, arthogalin, a cyclic depsipeptide (Huneck and Himmelreich, 1995) , and other amino acid-derived compounds such as the cytotoxic scabrosin esters isolated from Xanthoparmelia scabrosa (Ernst-Russell et al., 1999b) . Uncommon features are also detected in residues of common substance classes, in the form of other intramolecular arrangements, or in the binding with other compounds such as sugars. Recently, Rezanka et al. described many unusual compounds as brominated depsidones (Rezanka and Gushina, 1999) , brominated acetylenic fatty acids (Rezanka and Dembitsky, 1999) and monotetrahydrofuranic acetogenin derivatives (Rezanka et al., 2004) . Series of g-lactonic aliphatic acid glycosides were also identified Gushina, 2000, 2001a, b) , some of them forming a macrolactone ring (gobienins: Rezanka and Gushina, 2001c) . Glycosides are not frequently encountered in lichens, yet, recent reports revealed the presence of xanthone glucosides (umbilicaxanthosides: Rezanka et al., 2003) and the mycosporine collemin A from Collema cristatum (Torres et al., 2004) .
Evolutionary patterns of secondary chemistry in lichenized Ascomycotina
The presence of secondary compounds in cultured mycobionts and their absence in algae show that secondary products of lichens are generally formed by the fungus (e.g. Ahmadjian and Reynolds, 1961; Culberson and Armaleo, 1992) . Exceptions are strains of lichen-associated cyanobacteria, which may produce nostoclides (Yang et al., 1993) , oligopeptides such as microcystins (Oksanen et al., 2004) or derivatives of amino acids (Cox et al., 2005) . According to phylogenetic studies, the capacity of ascomycetous fungi to produce diverse and chemically complex compounds seems to have evolved during a principal evolutionary radiation, which gave rise to several major groups: Eurotiomycetes (including highly important and chemically diverse mould species), Lecanoromycetes, Leotiomycetes and Sordariomycetes (Lutzoni et al., 2004) . Interestingly, this basal evolutionary radiation includes also all major Lichens as a source of secondary metabolitesgroups of ascomycetous lichens. As a consequence, it was suggested that the potential to form lichen symbioses and richness in secondary compounds could be shared ancestral features of these ascomycetous lineages. While certain groups may have 'secondarily' lost a lichen habit during evolution, it was suggested that the genetic potential for secondary metabolite production is maintained (e.g. Eurotiomycetes, and groups in Chaetothyriomycetes; see Lutzoni et al., 2001) . The two large lineages of predominantly lichenized fungi-Lecanoromycetes and Arthoniomycetes-emerged independently, and while each of these groups contains some unique compounds, not found in the other, some other compounds are shared (and in certain cases also by other non-lichenized fungal groups). This suggests two possible evolutionary scenarios: either the corresponding biosynthetic pathways evolved prior to the divergence of Lecanoromycetes and Arthoniomycetes, or the shared compounds are the result of biosynthetic convergency. For the metabolites that are unique in evolutionary lineages, it may be hypothesized that pathways are lost or newly gained, either as a whole or by rearrangement of existing genetic material.
Differences in the presence of certain substance classes are sometimes observed among related lichen groups (see a compilation by Poelt and Leuckert, 1993) . For example, Xanthoparmelia and Neofuscelia, two closely related genera of the Parmeliaceae, differ primarily in the pigments of their upper cortex: while Xanthoparmelia contains crystallized usnic acid, the closely related genus Neofuscelia is characterized by melanin-like cortical pigments. Moreover, other members of the Parmeliaceae may exclusively contain atranorin in the cortex. Such compound replacements are also observed within genera, e.g. in Rhizocarpon. There, the crystallized extracellular pulvinic acid derivative rhizocarpic acid, a bright yellow compound, is repeatedly lost in several phylogenetic lineages of this genus (Ihlen and Ekman, 2002) , and replaced by melanin-like cell-wall pigments. It has not been clarified whether the production of rhizocarpic acid is suppressed in the latter species, whether the corresponding genes degenerated by mutation, or were lost, or whether the dark wall pigments could result from a polymerization of certain shared precursors. On the other hand, compounds which characteristically occur in large evolutionary lineages-such as anthraquinones throughout the yellow-coloured Teloschistaceae-may have a comparatively dispersed occurrence in other lineages.
As is apparent from the examples above, it is not possible to use chemical differences pragmatically to assess relationships of fungi without respect to other characters. This is clearly found at all hierarchic levels of relationships. Especially within certain species complexes, chemosyndromatic variation (i.e. the optional presence of biogenetically close compounds) has caused much debate about 'proper' classification. Usually, morphologically similar lichens that differ in the presence of compounds of the same chemosyndrome are taxonomically interpreted as varieties or informally as chemotypes of the same species. However, as earlier studies of ribosomal DNA by DePriest (1994) show, chemotypes are not necessarily linked with particular genotypes in a species.
Differential expression of lichen compounds in vivo and in vitro
The lichen thallus, i.e. the characteristic vegetative body, has in many species a strict organization with different functional layers. This typically includes a surface layer (the upper cortex, usually containing only the mycobiont), an algal layer (containing the photobiont) and a medullary layer (containing the mycobiont). Lichen substances are often expressed differentially in these layers, and typical cortical substances can be distinguished from compounds usually found only in the medulla. This could be linked with their biological function: the cortical compounds are regarded as a kind of lightfilter, which is apparently not a function of compounds below the algal layers. In addition to the differences within a lichen thallus, the presence of substances in individuals of a species can also differ according to geographic, altitudinal or microhabitat conditions. For example, a North -South gradient was observed in Lecanora rupicola (Leuckert and Poelt, 1978) , where chemical strains that contain certain xanthones are more common in the Mediterranean range of the entire geographic distribution of this species. It is not known, however, whether this pattern is due to genetic differentiation of populations, to climatic reasons or to both.
Compound production may fluctuate with the seasons (Huneck et al., 2004; Gauslaa and McEvoy, 2005) , but is affected also by microclimatic fluctuations, as pale thalli are often observed under suboptimal light conditions. The phenolic content and distribution is modified according to direct UV radiations (mainly accumulation in the outer layers of the medulla) but chemical signals are also involved for a tuned adaptation of these organisms to drastic UV climate changes (Buffoni Hall et al., 2002) . In a series of papers, Solhaug and co-workers have successfully used acetone-rinsed lichen thalli as a tool to investigate resynthesis of secondary compounds. They showed that lichens start resynthesizing parietin and melanins as a response to hydration and UV-B radiation (Solhaug et al., 2003) . They have also shown that the parietin resynthesis in Xanthoria elegans increased with decreasing latitude (Nybakken et al., 2004) . Other research groups have looked upon the effects of UV-B radiation in the field and the potential damaging effects of the ozone depletion-related enhancements of shortwave radiation. In particular, the UV-screening roles of usnic acid have been given much focus, and results regarding its UV protection role are equivocal (BeGora and Fahselt, 2001; Bjerke et al., 2002; Buffoni Hall et al., 2002; Rancan et al., 2002) . The only long-term studies have shown that lichen activity can be seriously reduced by UV-B exposure (Solheim et al., 2002) , but that depside synthesis is more affected by warming than by UV-B radiation (Bjerke et al., 2003) .
Lichens synthesize significant amounts of substances only in permissive physiological stages. As a consequence, the production in axenic cultures can differ substantially from that in nature. A chemotype of the natural lichen Lecanora dispersa contains 2,7-dichlorolichexanthone as the major secondary compound, but cultured spore isolates, growing without the alga, produced pannarin and related depsidones instead (Leuckert et al., 1990) . Pannarin could not be confirmed in voucher materials of the natural source lichen, but the biosynthetic potential for this depsidone was proven for the species by a herbarium survey. Another unexpected result is the production of atranorin in Usnea hirta, when cultured in a modified LB medium , since this compound is not present throughout the entire genus Usnea. Moreover, Kon et al. (1997) found only very low amounts of the typical metabolites, i.e. usnic acid, salazinic acid, in cultures of Usnea orientalis, while these rather produced the dibenzofuranes hypostrepsilic acid and isostrepsilic acid. The list of cases where metabolites are found in culture but not present in lichens can be extended further (Mosbach, 1967; Fox and Huneck, 1969; Ejiri et al., 1975; Hamada and Ueno, 1987; Miyagawa et al., 1994; Yamamoto et al., 1996; Tanahashi et al., 1997; Stocker-Wörgötter, 2002a) . Interestingly, if the mycobionts were co-cultured with their original photobionts, the natural metabolite pattern was restored. These findings indicate that a wider variation of metabolites can be induced in culture than found in natural lichen thalli.
An influence of agar concentration on the efficiency of usnic acid production in cultured Usnea hirta was indicated by Kinoshita et al. (1993) . Several other studies indicated that osmotically stressed mycobiont cultures seem to induce the biosynthesis of certain secondary metabolites (Yamamoto et al., 1985; Hamada, 1988 Hamada, , 1989 Hamada, , 1993 Miyagawa et al., 1993) , and this includes also the synthesis of new compounds, which do not occur in the natural lichen (e.g. Amano et al., 2000) . The effects of osmotic stress on the efficiency of metabolite production under natural conditions also deserve further studies, as Solhaug and Gauslaa (2004) showed that resynthesis of secondary metabolites in acetonesoaked thalli is promoted by exposure to osmolytes.
By using a modified Sabouraud medium, StockerWörgötter (2001) could achieve a higher degree of morphology differentiation in the cultured mycobiont, and, as a consequence, the expression of species-characteristic secondary metabolites in the Cladonia verticillaris complex. A study by suggests that the biosynthesis of compounds may be determined by stage and organization-specific factors. They showed that mycobiont cultures derived from spores and thallus fragments differ in their secondary metabolite patterns. While spore-derived cultures of Bunodophoron patagonicum are able to produce both dibenzofuranes and depsides, for unknown reasons, cultures of thallus fragments produced only depsides. For selected further species, Stocker-Wörgötter (2002b) described further how culture conditions can modify the expression of lichen compounds. It is apparent that in most cases high light conditions are promoting similar compound expression patterns of cultured mycobionts and natural lichen samples.
Genes involved in production of secondary metabolites
As far as we know today, the biosynthesis of fungal secondary products is encoded by clusters of sequentially arranged genes (e.g. Keller and Hohn, 1997) . For the production of polyketides the first essential step is the concatenation of C2-units by polyketide synthases (PKS). Hence, these enzymes synthesize the basic structure of a secondary metabolite. Fungal PKS genes encode multifunctional proteins (fungal type I PKSs) with only a single, reiteratively used ketoacyl synthesis domain that sequentially condensates C2-units. The gene fragment encoding this domain can be targeted by PCR primers (Bingle et al., 1999; Lee et al., 2001; Miao et al., 2001; Nicholson et al., 2001; Sauer et al., 2002; Grube and Blaha, 2003; Schmitt et al., 2005) to establish a phylogeny. Grube and Blaha (2003) , using a heterologous primer approach, found that a gene from Xanthoria parietina was related to genes that encode for the production of aflatoxins or similar mycotoxins. Since anthraquinones are precursors of these mycotoxins and due to the presence of the crystallized anthraquinone parietin in the upper cortex of Xanthoria, it was reasonable to suggest that this gene represents an anthraquinone-producing polyketide synthase.
In Fig. 2 , a preliminary Bayesian phylogenetic tree is presented for predicted amino acid sequences of ketoacyl synthase domains, which are part of fungal PKSs that putatively produce non-reduced polyketides. Unique PCR products were obtained from total DNA extracts of lichens with the primers LC1-LC2 (Bingle et al., 1999) . While the represented genes from the lichen families Physciaceae (# in Fig. 2 ) and Verrucariaceae ( § in Fig. 2 ) form monophyletic lineages and correspond well with the known relationships among the taxa within these orders, the relationship of sequences in Lecanora (Lecanoraceae; *in Fig. 2) does not reflect the species relationships within that genus and likely represent paralogous genes. Another paralogous gene from Lecanora groups more closely with a gene from Parmelia (Parmeliaceae), whereas other members of Parmeliaceae (in boldface in Fig. 2 ) contain further paralogous genes that are widely dispersed in the tree, and often group with paralogs of non-lichenized fungi. This pattern certainly represents just the peak of an iceberg and it is rather possible that numerous paralogous PKS genes evolved by complex patterns of gene duplications in lichen mycobiont genomes. Meanwhile, bioinformatic approaches are used to explore completely sequenced genomes of non-lichenized fungal model organisms for polyketide synthases (Kroken et al., 2003; Varga et al., 2003) . As lichen fungal genomes have so far not been sequenced, the results from non-lichenized fungi are taken as a framework for more detailed investigations of paralogy and functional divergence of polyketide synthases also in lichens. The heterologous primers for PKS genes known so far will preferentially amplify one gene or a few genes from a subset of paralogs in lichen genomes, therefore the discovery of additional PKS genes can follow three approaches: (i) cloning of PCR products obtained with primers of low specificity for different paralogs (Schmitt et al., 2005) , (ii) amplification with more specific primers for particular paralog lineages (M. Opanowicz and M. Grube, unpublished) , and (iii) screening of genomic libraries of lichen mycobionts using PKS gene probes (Miao et al., 2001) . Perhaps due to the slow growth in culture, genomic libraries of lichen mycobionts are rare. However, they will be extremely useful for characterizing full-length PKS genes and additional genes that form biosynthetic pathway gene clusters in lichens.
While these approaches will clearly increase our knowledge about the diversity of polyketide synthesis in lichen mycobionts, there is still a long way to go until we begin to understand the function of these genes and their contribution to the production of secondary metabolites. This will definitely also involve further experimental studies, such as the analysis of transcribed PKS paralogs, and perhaps also their expression in heterologous hosts.
Yet, studies of full-length genes from lichens and their use in biotechnological approaches were accomplished only once. Orotidine 5 0 -monophosphatase-responsible for the decarboxylation of orotidylic acid to uridylic acid-was recovered from a phage library of the lichen Solorina crocea with hybridization methods (Sinnemann et al., 2000) . Heterologous expression in Aspergillus nidulans indicated temperature sensitivity in the absence of uridine, suggesting an adaptation to lower temperature of the lichen enzyme. Because Solorina crocea is a lichen that grows at higher altitudes, this result fits well with the ecology of the species. Many other lichens can grow under rather hostile environmental conditions, therefore similar studies could reveal a number of other enzymes with interesting physiological adaptations.
Bioactive compounds and potential medicinal use
The wide variety of biological activities of lichens is generally correlated to their special ecological circumstances (e.g. Lawrey, 1986 Lawrey, , 1995 Rikkinen, 1995) , with production of metabolites involved in antimicrobial actions and deterrent properties (sometimes highly toxic to certain animals). Some review articles recently underlined the pharmaceutical potential of these substances (e.g. Huneck, 1999; Yamamoto, 2000; Muller, 2001) . For centuries, lichens have also been used in folk medicine (Richardson, 1988; Schindler, 1988; Hawksworth, 2003) . Commercial preparations based on the presence of usnic acid are available in some countries for local antiseptic activity and many properties have been described for this compound (for a review see Ingólfsdóttir, 2002) . Usnic acid, like many other lichen compounds, causes allergic reactions, but a recent incident of some hepatotoxicity was attributed to usnic acid due to its inadequate use in nutraceuticals (about 500 mg a day taken orally to lose weight; Durazo et al., 2004; Neff et al., 2004) . Lichens are still part of folk and alternative medicines in Asian countries (e.g. Benalu teh w ) with various indications (Saklani and Upreti, 1992) , and in the European Pharmacopoiea (2005), Iceland moss (¼ Cetraria islandica) is included and indicated uses correspond to a cough remedy and to a tonicum amarum. Lobaria pulmonaria has also been used as a cough remedy based on its lung-shaped appearance, and is still used in homeopathy (as Sticta pulmonaria). Together with recent studies on the antifungal activities of some Indian lichens (Shahi et al., 2000 (Shahi et al., , 2001 (Shahi et al., , 2003 , considerable information is available on ethnobotanical utilization of lichens by the different ethnic groups in India (Brij Lal and Upreti, 1985; Brij Lal et al., 1985; Brij Lal, 1988; Singh et al., 2000; Kumar and Upreti, 2001 ). The pharmacological and other biological activities of lichens and lichen substances can be divided into the following categories based on current knowledge.
Antibiotic activity
A number of lichen extracts and compounds were screened for antibacterial activity in the 1950s and in many cases activity was confirmed against mycobacteria and Gram-positive organisms (Stoll et al., 1950) . A review of the work performed during this period is presented in Vartia (1973) . More recent reports include a study describing the antimicrobial screening of lichen extracts and subsequent isolation of compounds with a broad spectrum of activity against yeast as well as Gram-positive and -negative bacteria (Ingólfsdóttir et al., 1985) . The in vitro activity of usnic acid against pathogenic Gram-positive organisms has been confirmed (Ghione et al., 1988) and it has been used in topical preparations, mouthwash and toothpaste. In addition, the compound was reported active against anaerobic bacteria, e.g. Bacteroides species and Clostridium perfringens (Lauterwein et al., 1995) . In light of the use of Iceland moss for the treatment of gastric and duodenal ulcers, it is noteworthy that a constituent of this lichen, protolichesterinic acid, has been shown to exhibit in vitro activity against Helicobacter pylori (Ingólfsdóttir et al., 1997) . The emergence of drug-resistant bacterial strains, e.g. in the case of tubercular mycobacteria, has currently led to severe clinical complications. Hence, new antimicrobial agents are urgently needed and as the search is being extended to new sources, lichens are clearly an interesting source of compounds.
Antitumour and antimutagenic activity
Some lichen substances have been partially investigated for antitumour and antimutagenic activity: (2)-usnic acid, a dibenzofuran with an antitumoral effect against Lewis Lung carcinoma and P388 leukaemia (Kupchan and Kopperman, 1975; Takai et al., 1979) was found to be involved in mitosis inhibition (Huovinen and Lampero, 1989; Cardarelli et al., 1997) and apoptotic induction (Bézivin et al., 2004) . The butyrolactone, protolichesterinic acid, was also found active as an antiproliferative against leukaemia cells K-562 (IC 50 ¼ 20 mg/ml) and against Ehrlich solid tumour, while nephrosteranic acid derivatives have a poor activity (Hirayama et al., 1980) . Polyporic acid (a terphenylquinone) and derivatives (Cain, 1961 (Cain, , 1966 , a depsidone, physodalic acid (Shibamoto and Wei, 1984) , lichen glucans (Nishikawa et al., 1969 (Nishikawa et al., , 1979 Hirayama et al., 1980; Nishikawa and Ohno, 1981; Hirabayashi et al., 1989) including lichenin derivatives (Demleitner et al., 1991) have also been investigated in this way. A review was recently published on structure features and bioactivities of lichen polysaccharides (Ó lafsdóttir and Ingólfsdóttir, 2001) . Concerning new lichen secondary metabolites that exhibit relevant cytotoxic activities against cancer cell lines, original N-containing complex structures (scabrosin esters) isolated from Xanthoparmelia scabrosa (IC 50 ¼ 0.27 mM p-815), an unusual indenone naphthopyrone euplectin from Flavoparmelia euplecta (IC 50 ¼ 0.58 mM, P-815), and a naphthazarin-derived dimer (hybocarpone) isolated from a mycobiont culture of Lecanora hybocarpa (IC 50 ¼ 1 nM, MCF-7), have been recently described (Ernst-Russell et al., 1999a, b) .
Extracts from lichens of various countries were evaluated in several predictive tests (including in vitro antiproliferation of cancer cells, Brine shrimp test and cancer chemopreventive assays; Nascimento et al., 1994; Esimone et al., 1999; Ingólfsdóttir et al., 2000 , Bézivin et al., 2003 . Most of them were found active with IC 50 , 20 mg/ml. Depsidone and depside series such as pannarin, 1
0 -chloropannarin and sphaerophorin tested in cell cultures of lymphocytes were shown to have a higher cytotoxic effect than colchicine (Correché et al., 2002) . The depsidones salazinic acid, stictic acid and psoromic acid were the most apoptotic active derivatives among 15 lichen compounds evaluated on primary cultures of rat hepatocytes (Correché et al., 2004) .
Antiviral activity
Some anthraquinonic compounds which are also encountered in higher plants (emodin and derivatives) have shown in vitro antiviral activity considered of interest against Human Cytomegalovirus (Wood et al., 1990) . Seventeen depsides and depsidones have been examined for their inhibitory activity against HIV integrase and pharmacophores derived from virensic acid allowed selection of various potent inhibitors (Neamati et al., 1997) . The butyrolactone, protolichesterinic acid, isolated from Cetraria islandica, was also found to inhibit HIV-RT (Pengsuparp et al., 1995) . Four depsides and above all (þ)-usnic acid were found active against EBV activation and could therefore constitute valuable candidates as antitumour promoters . Concerning high molecular weight compounds, a sulphate (GE-3-S) prepared by chlorosulphonic acid treatment of GE-3, a partially acetylated (1 ! 6) glucan from the lichen Umbilicaria esculenta, inhibited the cytopathic effect of HIV in vitro (Hirabayashi et al., 1989) .
Enzyme inhibitory activities
Lichen acids, mainly atranorin, evernic, physodic and usnic acids, are powerful inhibitors of some metabolic enzymes, interestingly related to polyamine metabolism, such as arginase, arginine decarboxylase, ornithine decarboxylase, etc. (Legaz et al., 1983 Planelles and Legaz, 1987; Okuyama et al., 1991; Matsubara et al., 1997 Matsubara et al., , 1998 Kinoshita et al., 2002) .
Inhibition of lipoxygenase has also been demonstrated for some lichen extracts and compounds (Ingólfsdóttir et al., 1985 (Ingólfsdóttir et al., , 1994 Ö gmundsdóttir et al., 1998) . The inhibition of prostaglandin biosynthesis (Sankawa et al., 1982) as well as the inhibition of leukotriene B4 biosynthesis depicted by Kumar and Muller (1999) can be related to the anti-inflammatory activity, analgesic and antipyretic activities (Okuyama et al., 1995) and local anaesthesic effect (Correia Da Silva, 1981) of some lichen compounds.
Inhibition of xanthine oxidase (a key enzyme in hyperuricaemia) and of tyrosinase (involved in melanin biosynthesis) by extracts of natural lichens (Behera et al., 2004) or cultured lichen tissue (Higuchi et al., 1993; Behera and Makhija, 2002) was found in cases to be superior to the assay standards used. Tyrosinase inhibitors such as divarinol or diphenylmethane derivatives have been isolated (Matsubara et al., 1997) and more potent derivatives obtained by synthesis (Matsubara et al., 1998) .
Due to the phenolic nature of most of the lichen compounds, many antioxidant activities (Hidalgo et al., 1993 (Hidalgo et al., , 1994 Jayaprakasha and Rao, 2000) and superoxide scavenging properties (Behera et al., 2004) have been described. Such properties, as well as the metal-chelating ability and UV-filtering performances of a number of these compounds (Stepanenko et al., 2002) , should lead to various applications of these or their derivatives for protective or environmental purposes.
Future prospects: new and hemisynthetic lichen compounds and chimeric genes
Total synthesis of some lichen compounds has been achieved Huneck, 2001; Nicolaou and Gray, 2004) . Pharmacomodulation of active lichen compounds has been initiated with usnic acid coupled to various amines and polyamines using an unusual chemical way (Ouzzine et al., 2001 ) but also performed using solid-phase organic synthesis (SPOS, MultiPins w Chiron; Ouzzine et al., 2001) .
In the Vicente and Legaz Laboratory (Blanch et al., 2001 (Blanch et al., , 2002 Fontaniella et al., 2000) , detection of free and conjugated polyamines to lichen phenolics has been extensively studied in several lichen taxa (Evernia, Pseudevernia and Xanthoria). In addition, the use of bioreactors consisting of both cells and enzymes immobilized in several matrices (alginate, kaolinite, polyacrylamide) is applied to elucidate the nature of enzymes involved in the production of depsides and depsidones by Evernia and Pseudevernia species. Affinity binding with such enzymes is also useful for characterization and purification of lichen compounds (Molina and Vicente, 2000; Legaz et al., 2001) .
Purification and identification of lichen compounds is a challenge of importance generally managed by crystallization or chromatographic techniques, and some special techniques such as supercritical CO 2 should be more developed (Lisickov et al., 2002) . As many secondary metabolites are currently found in various lichens, the use and development of standardized methods is crucial for a dereplicative approach. Thin-layer chromatography (Culberson and Kristinsson, 1970; Culberson, 1972; BeGora and Fahselt, 2000) and high-performance liquid chromatography (Huovinen et al., 1985; Huovinen, 1987; Feige et al., 1993; Yoshimura et al., 1994) procedures have been developed. To deal with small amounts of material more refined techniques such as thermochemolysis -gas chromatography (MacGillivray and Helleur, 2001) , solid-phase microextraction -gas chromatography -mass spectrometry (De Angelis et al., 2003) or Fourier-transform Raman (Edwards et al., 2003) can be used. Thus, a focus on minor compounds, generally complicated by the relatively high abundance of some lichen compounds should allow findings of more specific and interesting compounds.
Genetic technology can now also be used to design chimeric genes with novel functions. An interesting case has been demonstrated in Aspergillus, where a novel hexaketide naphthalene was synthesized by a polyketide synthase that was derived from the combination of gene fragments of pentaketide and heptaketide synthases (Watanabe and Ebizuka, 2002) . Such pioneering experiments can contribute to combinatorial approaches for the production of novel bioactive compounds. With their diversity of metabolites, lichenized fungi could provide an interesting set of genes for such future prospects.
Conclusions
The above-mentioned activities clearly indicate the potential of lichen compounds for pharmaceutical purposes, but some properties of lichens still need consideration. Their slow growth, both in nature and in axenic cultures, may be regarded as a major problem for the production of metabolites. However, culture conditions of lichen mycobionts can be optimized in order to support the synthesis of interesting secondary compounds. Much progress has been achieved recently by specifically addressing these issues (Stocker-Wörgötter, 1998 , 2002a ).
On the other hand, the large amount of compounds in a lichen thallus (extraction yields often between 5 and 25% of dried lichen material) may be sufficient both for testing, even though many cases require special solubilization efforts (Kristmundsdóttir et al., 2002) , and for direct crystallizations. This may be of interest for pharmacological purposes, as direct crystallizations facilitate the isolation and characterization of compounds and will also allow their derivatization and hemisynthetic studies. In parallel, progress in the investigation of the rich genetic treasure of polyketide synthase genes may revolutionize their use in future biotechnological approaches, including heterologous expression in fast-growing hosts and the design of chimeric molecules.
New compounds are to be described from poorly studied lichens, and even in species that are considered chemically well known, new chemical strains are still detected (e.g. . Particularly in tropical habitats, many lichens are known which contain structurally unknown lichen products. Here we are at the entrance door of a vast and interesting field of research.
